The SEC is plugged into the potential pitfalls of making Covid-19 vaccines

Katherine Ellen Foley
The SEC is plugged into the potential pitfalls of making Covid-19 vaccines

When reading news about potential vaccines for Covid-19, healthy skepticism is your friend. No ones knows this better than pharmaceutical companies developing them. Most of these companies are publicly-traded, which means they’re legally required to notify shareholders (and potential shareholders) of any developments that could change the value of their assets—like a successful clinical trial.